EADERM

EADERM is a biotech company in Japan. It has raised $3.2M across 1 round, most recently a $3.2M Series A in June 2025.

Small molecule therapeutics targeting epithelial stem cell regeneration

Employees
1–10
Business Model
B2B
Website
eaderm.com
Total Funding
$3.2M
Last Round
$3.2M Series AJun 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

EADERM (株式会社イーダーム) is a Japanese drug discovery biotechnology startup developing innovative small-molecule therapeutics based on tissue stem cell science, focused on skin and hair conditions. The company's proprietary platform targets epithelial stem cell protection and quality control mechanisms in vivo, enabling discovery of novel drug candidates for alopecia (hair loss), pressure ulcers (bedsores), and rare diseases such as progeria. EADERM's research and development pipeline aims to address disease mechanisms through stem cell regulation rather than symptomatic treatment. In July 2026, the company announced an exclusive evaluation and license option agreement with Rohto Pharmaceutical.

Summary

It lists 1–10 employees. It has raised $3.2M in total across 1 round, most recently a $3.2M Series A round in Jun 2025. Investors include UntroD Capital and ANRI.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2025
$3.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EADERM on Indexed.vc
<a href="https://indexed.vc/companies/eaderm"><img src="https://indexed.vc/api/badge/company/eaderm" alt="EADERM on Indexed.vc" width="260" height="76" /></a>